Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 22 November 1996:
Vol. 274. no. 5291, pp. 1393 - 0
DOI: 10.1126/science.274.5291.1393
Prev | Table of Contents | Next

Technical Comments

C. E. Mackewicz, E. Barker, J. A. Levy;, F. Cocchi, A. L. DeVico, A. Garzino-Demo, P. Lusso, R. C. Gallo


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
VCAM-1 Expression on CD8+ Cells Correlates with Enhanced Anti-HIV Suppressing Activity.
L. S. Diaz, H. Foster, M. R. Stone, S. Fujimura, D. A. Relman, and J. A. Levy (2005)
J. Immunol. 174, 1574-1579
   Abstract »    Full Text »    PDF »
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
S. F. Abdelwahab, F. Cocchi, K. C. Bagley, R. Kamin-Lewis, R. C. Gallo, A. DeVico, and G. K. Lewis (2003)
PNAS 100, 15006-15010
   Abstract »    Full Text »    PDF »
Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules.
C. E. Mackewicz, B. Wang, S. Metkar, M. Richey, C. J. Froelich, and J. A. Levy (2003)
Blood 102, 180-183
   Abstract »    Full Text »    PDF »
The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.
C. E. Mackewicz, C. S. Craik, and J. A. Levy (2003)
PNAS 100, 3433-3438
   Abstract »    Full Text »    PDF »
HIV-1 gp120 Stimulates the Production of {{beta}}-Chemokines in Human Peripheral Blood Monocytes Through a CD4-Independent Mechanism.
L. Fantuzzi, I. Canini, F. Belardelli, and S. Gessani (2001)
J. Immunol. 166, 5381-5387
   Abstract »    Full Text »    PDF »
CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription.
S. Le Borgne, M. Février, C. Callebaut, S. P. Lee, and Y. Rivière (2000)
J. Virol. 74, 4456-4464
   Abstract »    Full Text »
Resistance against Syncytium-Inducing Human Immunodeficiency Virus Type 1 (HIV-1) in Selected CD4+ T Cells from an HIV-1-Infected Nonprogressor: Evidence of a Novel Pathway of Resistance Mediated by a Soluble Factor(s) That Acts after Virus Entry.
K. Saha, D. J. Volsky, and E. Matczak (1999)
J. Virol. 73, 7891-7898
   Abstract »    Full Text »
Sensitivity of human immunodeficiency virus infection to various {alpha}, {beta} and {gamma} chemokines.
G. Greco, C. Mackewicz, and J. A. Levy (1999)
J. Gen. Virol. 80, 2369-2373
   Abstract »    Full Text »
Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytotoxic anti-HIV response.
S. A. Stranford, J. Skurnick, D. Louria, D. Osmond, S.-Y. Chang, J. Sninsky, G. Ferrari, K. Weinhold, C. Lindquist, and J. A. Levy (1999)
PNAS 96, 1030-1035
   Abstract »    Full Text »    PDF »
Differential Effects of Human Immunodeficiency Virus Isolates on beta -Chemokine and Gamma Interferon Production and on Cell Proliferation.
G. Greco, S. H. Fujimura, D. V. Mourich, and J. A. Levy (1999)
J. Virol. 73, 1528-1534
   Abstract »    Full Text »
Negative Feedback Between Prostaglandin and {alpha}- and {beta}-Chemokine Synthesis in Human Microglial Cells and Astrocytes.
N. Janabi, I. Hau, and M. Tardieu (1999)
J. Immunol. 162, 1701-1706
   Abstract »    Full Text »    PDF »
Virological and Immunological Features of Long-Term Human Immunodeficiency Virus-Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency Syndrome.
E. Barker, C. E. Mackewicz, G. Reyes-Teran, A. Sato, S. A. Stranford, S. H. Fujimura, C. Christopherson, S.-Y. Chang, and J. A. Levy (1998)
Blood 92, 3105-3114
   Abstract »    Full Text »    PDF »
Endogenous Production of beta -Chemokines by CD4+, but Not CD8+, T-Cell Clones Correlates with the Clinical State of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals and May Be Responsible for Blocking Infection with NonSyncytium-Inducing HIV-1 In Vitro.
K. Saha, G. Bentsman, L. Chess, and D. J. Volsky (1998)
J. Virol. 72, 876-881
   Abstract »    Full Text »    PDF »
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
S. A. Stranford, J. C. Ong, B. Martinez-Marino, M. Busch, F. M. Hecht, J. Kahn, and J. A. Levy (2001)
PNAS 98, 597-602
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)